Evolution in Clinical Trials Seminar - 31st October
Phase I trials have evolved.
EU Legislative developments have redefined the boundaries of Phase I and opened a new era of opportunity to expedite compounds through the Early Phases. Pharmacology and patient studies can now be integrated or work independently of one another. Clinical & therapeutic innovations now enable Early Phase research to deliver more dynamic and insightful studies, maximizing the probability of a compound reaching the later Phases.
This new era of Early Phase research demands 3 foundations:
- Commercial in- and out-patient facilities
- Acute NHS environment
- Therapeutic expertise
Richmond Pharmacology has arranged this one-day seminar to consider these foundations and to explore how the Pharmaceutical industry can maximize the efficiency and speed of their Early Phase research.
